About Oric Pharmaceuticals, Inc. Common Stock
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Market Cap
$0.42B
Employees
115
Listed Since
April 24, 2020
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.oricpharma.comPhone
(650) 388-5600
Headquarters
240 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA 94080
CIK
0001796280
No content available for this security